Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models.
Convection-enhanced delivery (CED) of therapeutic agents is a promising local delivery technique that has been extensively studied as a treatment for CNS diseases over the last two decades. One continuing challenge of CED is accurate and consistent delivery of the agents to the target. The present study focused on a new type of therapeutic agent, NK012, a novel SN-38-loaded polymeric micelle. Local delivery profiles of NK012 and SN-38 were studied using rodent brain and intracranial rodent brain tumor models. First, the cytotoxicity of NK012 against glioma cell lines was determined in vitro. Proliferations of glioma cells were significantly reduced after exposure to NK012. Then, the distribution and local toxicity after CED delivery of NK012 and SN-38 were evaluated in vivo. Volume of distribution of NK012 after CED was much larger than that of SN-38. Histological examination revealed minimum brain tissue damage in rat brains after delivery of 40 µg NK012 but severe damage with SN-38 at the same dose. Subsequently, the efficacy of NK012 delivered via CED was tested in 9L and U87MG rodent orthotopic brain tumor models. CED of NK012 displayed excellent efficacy in the 9L and U87MG orthotopic brain tumor models. Furthermore, NK012 and gadolinium diamide were co-delivered via CED to monitor the NK012 distribution using MRI. Volume of NK012 distribution evaluated by histology and MRI showed excellent agreement. CED of NK012 represents an effective treatment option for malignant gliomas. MRI-guided CED of NK012 has potential for clinical application.
a Department of Neurosurgery , Tohoku University Graduate School of Medicine , Sendai , Miyagi , Japan and.
Rong
R
Zhang
a Department of Neurosurgery , Tohoku University Graduate School of Medicine , Sendai , Miyagi , Japan and.
Ryuta
R
Saito
a Department of Neurosurgery , Tohoku University Graduate School of Medicine , Sendai , Miyagi , Japan and.
Yui
Y
Mano
b Department of Functional Brain Imaging , Institute of Development, Aging and Cancer, Tohoku University , Sendai , Miyagi , Japan.
Akira
A
Sumiyoshi
a Department of Neurosurgery , Tohoku University Graduate School of Medicine , Sendai , Miyagi , Japan and.
Masayuki
M
Kanamori
a Department of Neurosurgery , Tohoku University Graduate School of Medicine , Sendai , Miyagi , Japan and.
Yukihiko
Y
Sonoda
b Department of Functional Brain Imaging , Institute of Development, Aging and Cancer, Tohoku University , Sendai , Miyagi , Japan.
Ryuta
R
Kawashima
a Department of Neurosurgery , Tohoku University Graduate School of Medicine , Sendai , Miyagi , Japan and.
Teiji
T
Tominaga
D000818:Animals; D001921:Brain / Q000187:drug effects*; D001932:Brain Neoplasms / Q000188:drug therapy*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry; D045744:Cell Line, Tumor; D018481:Convection; D016503:Drug Delivery Systems / Q000379:methods; D005682:Gadolinium / Q000737:chemistry; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D000077146:Irinotecan; D008297:Male; D051379:Mice; D008823:Micelles; D011108:Polymers / Q000737:chemistry; D051381:Rats; D011916:Rats, Inbred F344; D011923:Rats, Nude
D008823:Micelles; D011108:Polymers; D000077146:Irinotecan; D005682:Gadolinium; D002166:Camptothecin
Chemotherapy; SN-38; convection-enhanced delivery; malignant glioma; micelle